Hongyong Fu

发表

PRAS40 hyperexpression promotes hepatocarcinogenesis

T. Ma, Yingjie Wu, Shuyun Zhao, 2020, EBioMedicine.

An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease

Yang Zhang, Fang Yang, Jian-Xing Luo, 2022, Evidence-based complementary and alternative medicine : eCAM.

AnOpen-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast GrowthFactor21 inPatientswithNonalcoholicFattyLiverDisease

Yang Zhang, Fang Yang, Jian-Xing Luo, 2022 .

Gastro‑oesophageal reflux disease in liver cirrhosis: Possible pathogenesis and clinical intervention (Review)

Xiaoyu Hu, Na Li, Fei Yu, 2023, Experimental and therapeutic medicine.